SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Alteon (ALT) -- Ignore unavailable to you. Want to Upgrade?

To: VoodooFL who wrote (207)2/10/1998 4:05:00 PM
From: Mac S. Giballa  Read Replies (1) | Respond to of 318
 
Time for the next move to $12-$14. I would expect a steady flow of buy recommendations in the next three months.
One note of caution would be the upcoming final ESMC for ACTION-1. This late into the trial the only risk would be that they detect some unanticipated toxicity. I may sell half my shares in late February (as long as the price is >12), and buy back after the ESMC.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News